Debt to EBITDA ratio Analysis of ZyVersa Therapeutics Inc. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of ZVSA
Dec-23-0.097Very Poor Debt to EBITDA | Dec-220Excellent Debt to EBITDA | Growth-59548347.24% |
Debt to EBITDA Analysis of ZyVersa Therapeutics Inc.
| Debt to EBITDA Ratio of ZVSA drastically fell by -59548347.24 % this year. |
Other Debt to EBITDA Related Info of ZVSA that may interest you.
ZyVersa Therapeutics Inc. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ZVSA | 4.94 | 4.08 | 21.08 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Mild Stability | |
FY - Historical Debt to EBITDA of ZyVersa Therapeutics Inc.
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
|---|---|---|---|---|
| Debt to EBITDA | -0.097 | 0 | -1.26 | -0.314 |
| Change | -59548347.24 % | 100.00 % | -301.86 % |
FY Chart of Debt to EBITDA of ZyVersa Therapeutics Inc.
Note : All Data Generated at the End of Trading Hours (EOD Data)